ASCO-slider Eye on ASCO Day 4 - Moonshots, Money and Mobile apps You don't often get searched by the US secret service at a medical meeting.
News BMS's Breyanzi is first CAR-T for marginal zone lymphoma Bristol Myers Squibb has taken CAR-T therapy into new territory, after getting FDA approval for Breyanz in marginal zone lymphoma.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.